DOMENICO COPPOLA, MD
Medical Practice at Usf Magnolia Dr, Tampa, FL
License number
Florida ME69155
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
2
12902 Usf Magnolia Dr, Tampa, FL 33612
PO Box 917770, Orlando, FL 32891
PO Box 917770, Orlando, FL 32891
Phone
(813) 745-3275
(813) 745-1708 (Fax)
(813) 745-1708 (Fax)
Personal information
See more information about DOMENICO COPPOLA at radaris.comName
Address
Phone
10525 Bermuda Isle Dr, Tampa, FL 33647
16512 Lonesdale Pl, Tampa, FL 33624
8702 Windelstraw Way, Tampa, FL 33647
8702 Windelstraw Way, Tampa, FL 33647
10525 Bermuda Isle Dr, Tampa, FL 33647
Professional information
Dr. Domenico Coppola, Tampa FL - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
Moffitt Cancer Center
12902 Usf Magnolia Dr, Tampa 33612
(813) 745-4673 (Phone), (813) 449-8210 (Fax)
12902 Usf Magnolia Dr, Tampa 33612
(813) 745-4673 (Phone), (813) 449-8210 (Fax)
Procedures:
Pathology
Conditions:
Gastrointestinal Cancer
Certifications:
Anatomic & Clinical Pathology
Awards:
Healthgrades Honor Roll
Languages:
English, Italian
Hospitals:
Moffitt Cancer Center
12902 Usf Magnolia Dr, Tampa 33612
H. Lee Moffitt Cancer Center and Research Institute I.
12902 Usf Magnolia Dr, Tampa 33612
12902 Usf Magnolia Dr, Tampa 33612
H. Lee Moffitt Cancer Center and Research Institute I.
12902 Usf Magnolia Dr, Tampa 33612
Philosophy:
Dr. Coppola has clinical and teaching responsibilities, and is a participating member of the Gastrointestinal Division. He developed the Moffitt Cancer Center Pathology Consultation Service and also is contributing to Total Cancer Care.
Education:
Medical School
Faculty Of Medicine Ii, University Of Naples
Graduated: 1983
University Naples
Monmouth Med Center
Graduated: 1988
Temple University
Graduated: 1992
Thomas Jefferson University
Graduated: 1994
University Of Pittsburgh
Graduated: 1995
Faculty Of Medicine Ii, University Of Naples
Graduated: 1983
University Naples
Monmouth Med Center
Graduated: 1988
Temple University
Graduated: 1992
Thomas Jefferson University
Graduated: 1994
University Of Pittsburgh
Graduated: 1995
Domenico P Coppola, Tampa FL
Specialties:
Pathologist
Address:
12902 Usf Magnolia Dr, Tampa, FL 33612
Education:
University of Naples, School of Medicine - Doctor of Medicine
UPMC Montefiore - Fellowship - Surgical Pathology
Thomas Jefferson University Hospital - Fellowship - Molecular Biology
Temple University Hospital - Residency - Pathology
Monmouth Medical Center - Residency - Surgery
UPMC Montefiore - Fellowship - Surgical Pathology
Thomas Jefferson University Hospital - Fellowship - Molecular Biology
Temple University Hospital - Residency - Pathology
Monmouth Medical Center - Residency - Surgery
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology)
Method For Early Detection Of Cancers
US Patent:
8309311, Nov 13, 2012
Filed:
Mar 24, 2010
Appl. No.:
12/730844
Inventors:
Hong-Gang Wang - Palmyra PA, US
Domenico Coppola - Tampa FL, US
Domenico Coppola - Tampa FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The invention includes methods for detecting the presence of a neoplastic condition by comparing a sample level of a BIF-1 to a reference, wherein a low level of BIF-1 in the sample correlates with the presence of a neoplastic condition. Another method involves determining the risk of relapse, tumor recurrence and/or metastasis by determining a sample level of a Bif-1 to a reference level of Bif-1, wherein low sample levels correlate with a likelihood of relapse, recurrence and/or metastasis. Yet another method includes detecting the presence of a pre-neoplastic condition, such as prostatic intraepithelial neoplasia. The method involves measuring a level of a Bif-1 in a sample and comparing the level of Bif-1 in the sample to a reference level of Bif-1. High levels of Bif-1 in the sample correlate with the presence of the pre-neoplastic condition.
Method For Early Detection Of Cancers
US Patent:
2013007, Mar 21, 2013
Filed:
Oct 23, 2012
Appl. No.:
13/658314
Inventors:
University of South Florida - Tampa FL, US
Domenico Coppola - Tampa FL, US
Domenico Coppola - Tampa FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
C40B 30/06, G01N 33/574
US Classification:
506 9, 435 71
Abstract:
The invention includes methods for detecting the presence of a neoplastic condition by comparing a sample level of a BIF-1 to a reference, wherein a low level of BIF-1 in the sample correlates with the presence of a neoplastic condition. Another method involves determining the risk of relapse, tumor recurrence and/or metastasis by determining a sample level of a Bif-1 to a reference level of Bif-1, wherein low sample levels correlate with a likelihood of relapse, recurrence and/or metastasis. Yet another method includes detecting the presence of a pre-neoplastic condition, such as prostatic intraepithelial neoplasia. The method involves measuring a level of a Bif-1 in a sample and comparing the level of Bif-1 in the sample to a reference level of Bif-1. High levels of Bif-1 in the sample correlate with the presence of the pre-neoplastic condition.
Methods Of Predicting High Grade Gliomas Using Senescence Associated Genes
US Patent:
2012032, Dec 20, 2012
Filed:
Aug 29, 2012
Appl. No.:
13/597753
Inventors:
Domenico Coppola - Tampa FL, US
Steven Brem - Haverford PA, US
Steven Brem - Haverford PA, US
Assignee:
H. Lee Moffitt Cancer Center and Research Institute, Inc. - Tampa FL
International Classification:
C40B 30/04, C12Q 1/68, G01N 33/574
US Classification:
506 9, 435 71, 435375, 435 612, 435 611, 435 613
Abstract:
The present invention relates to biomarkers for neoplasias such as high grade gliomas. The inventors have discovered that the overexpression of senescence associated genes (SAG) is associated with a poor prognosis in subjects with high grade gliomas. The present invention provides SAG biomarkers for predicting response to therapy for subjects having high grade glioma based on dividing the samples into high and low risk groups; diagnosing high grade glioma; monitoring progression of high grade glioma from one biological state to another; and determining efficacy of treatment for high grade gliomas.
Immune Gene Signatures In Cancer
US Patent:
2013003, Feb 7, 2013
Filed:
Jan 28, 2011
Appl. No.:
13/575354
Inventors:
James J. Mulé - Odessa FL, US
Domenico Coppola - Tampa FL, US
Timothy J. Yeatman - Thonotosassa FL, US
Andrey Loboda - Philadelphia PA, US
Domenico Coppola - Tampa FL, US
Timothy J. Yeatman - Thonotosassa FL, US
Andrey Loboda - Philadelphia PA, US
Assignee:
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. - Tampa FL
International Classification:
C40B 30/04, A61K 39/395, A61P 35/00, A61K 35/14, A61K 39/00, A61K 31/675, G01N 33/574, A61K 31/7088
US Classification:
4241301, 435 723, 506 9, 4242771
Abstract:
This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.